Abstract:1The ability of drugs to inhibit noradrenaline accumulation and to release noradrenaline was studied in the isolated anococcygeus muscle of the rat. 2 Noradrenaline, tyramine, 2-amino,6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene (ADTN), 2-amino,6,7-dimethoxy-1,2,3,4-tetrahydronaphthalene (dimethyl ADTN), and 5-hydroxytryptamine were all potent inhibitors of noradrenaline accumulation and potent releasers of noradrenaline. ADTN was accumulated by the rat isolated anococcygeus muscle. 3 Amphetamine and desipramin… Show more
“…These results suggest that the smooth muscle of rat anococcygeus also possesses angiotensin II receptors, as has been previously suggested (Doggrell & Woodruff, 1978), and provides further evidence for the local conversion of angiotensin I to angiotensin II in this tissue.…”
4 Isoprenaline (0.1 pM) slightly enhanced the S-I efflux of radioactivity, and produced a greater enhancement after neuronal uptake blockade with desipramine (0.03 gM) and a-adrenoceptor blockade with phentolamine (1 pM).
5The facilitatory effect of isoprenaline on S-I efflux of radioactivity was abolished by propranolol (0.3 pM), but was not affected by low concentrations of saralasin (0.03 Mm) or captopril (0.1 Mm) which abolished the effect of angiotensin I. The findings suggest that isoprenaline acts directly on prejunctional f,-adrenoceptors to enhance S-I noradrenaline release, rather than indirectly by releasing angiotensin II from within the tissue. Higher concentrations of saralasin (0.1 M) or captopril (5 MM) did block the facilitatory effect of isoprenaline. The significance of this finding is not clear.
“…These results suggest that the smooth muscle of rat anococcygeus also possesses angiotensin II receptors, as has been previously suggested (Doggrell & Woodruff, 1978), and provides further evidence for the local conversion of angiotensin I to angiotensin II in this tissue.…”
4 Isoprenaline (0.1 pM) slightly enhanced the S-I efflux of radioactivity, and produced a greater enhancement after neuronal uptake blockade with desipramine (0.03 gM) and a-adrenoceptor blockade with phentolamine (1 pM).
5The facilitatory effect of isoprenaline on S-I efflux of radioactivity was abolished by propranolol (0.3 pM), but was not affected by low concentrations of saralasin (0.03 Mm) or captopril (0.1 Mm) which abolished the effect of angiotensin I. The findings suggest that isoprenaline acts directly on prejunctional f,-adrenoceptors to enhance S-I noradrenaline release, rather than indirectly by releasing angiotensin II from within the tissue. Higher concentrations of saralasin (0.1 M) or captopril (5 MM) did block the facilitatory effect of isoprenaline. The significance of this finding is not clear.
“…Activation of the prejunctional receptor results in enhancement of norepinephrine (NE) release, which induces contractile response by activation of postjunctional ␣ 1 -adrenoceptors (Doggrell and Woodruff, 1978;James and Leighton, 1987;Li et al, 1988). The ultrastructure of nerve terminals in the rat anococcygeus muscle also offers support for a nonadrenergic, noncholinergic enervation of approximately 40% of the nerve terminals (Gibbins and Haller, 1979).…”
Schild regressions for the selective AT 1 and AT 2 receptor antagonists, losartan and PD123319 (S-[ϩ]-1-[(4-dimethylamino]-3-methylphenyl)methyl]-5- [diphenylacetyl]-4,5,6,7-tetrahydro-1H-imidazol[4,5-c]pyridine-6-carboxilic acid), respectively, were calculated to analyze the heterogeneity of receptor populations in the rat anococcygeus muscle. For a one-receptor system, the Schild regression has a slope of unity and an intercept of K B for competitive antagonists. However, in a two-receptor system, a deviation from the single-receptor plot will occur. This is predicated on the assumption that the secondary receptor is less sensitive to the antagonist than the primary receptor. Results showed that the Schild regression for losartan did not produce a slope of unity, and PD123319 did not produce any effect. However, tissue incubation with losartan plus PD123319 resulted in a Schild regression that has a slope of unity and a pK B of 9.32. In the presence of prazosin, an ␣ 1 -adrenoceptor antagonist, losartan did not produce any effect. Conversely, PD123319 enhanced the angiotensin II (Ang II)-induced contraction in a concentration-dependent fashion, suggesting an inhibitory AT 2 -mediated effect. This effect was confirmed with assays that showed a relaxant response induced by Ang II on precontracted tissues incubated with prazosin. PD123319 and N G -nitro-L-arginine methyl ester [nitric-oxide (NO) synthase inhibitor)] markedly inhibited the relaxant response of Ang II. In contrast, losartan did not produce any significant effect. Consequently, results show that the mechanism underlying the AT 2 -mediated effect is highly dependent on NO generation. Results indicate the presence of a heterogeneous angiotensin receptor population in the rat anococcygeus muscle following a negative cross-talk relationship between the AT 1 and AT 2 subtypes.
“…However, the treatment with mianserin and nomifensin, that are also inhibitors of noradrenaline uptake (Richelson and Pfenning, 1984) did not modify the sensitivity of the anococcygeus muscle to the a~-adrenoceptor agonist phenylephrine. One interpretation arises taking into account that the %-adrenoceptor antagonism of nomifensine and mianserin in the rat anococcygeus muscle (Doggrell and Woodruff, 1977;Ishida et al, 1988) could overcome the desensitization due to the increase of synaptic noradrenaline which results from inhibition of monoamine neuronal uptake while desipramine and nortryptiline did not. In contrast with our results long-term treatment with imipramine produces an increase of a~-adrenoceptor sensitivity in the anococcygeus muscle (Hong et al, 1986).…”
Section: Discussionmentioning
confidence: 97%
“…It is known that tricyclic antidepressants inhibit neuronal noradrenaline uptake not only in the central nervous system (Richelson and Pfenning, 1984) but also in peripheral tissues such as the anococcygeus muscle (Doggrell and Woodruff, 1977). Thus, chronic increase in the availability of noradrenaline at its receptors, could lead to a development of adrenoceptor subsensitivity.…”
The effects of a single administration (48 hours) and of chronic (14 days) treatment with tricyclic (desipramine, nortryptiline) and nontricyclic (mianserin, nomifensine) antidepressant drugs on responses of the isolated anococcygeus muscle to the alpha 2-adrenoceptor agonist xylazine (inhibition of contraction to field stimulation at 1 Hz) and to the alpha 1-adrenoceptor agonist phenylephrine (contraction of the muscle) have been studied. Of the drugs used only desipramine and nortryptiline administered chronically reduced the responsiveness of the anococcygeus muscle to phenylephrine suggesting a desensitization of postsynaptic alpha 1-adrenoceptors. Long-term but not acute administration of antidepressants resulted in significant decrease in sensitivity of presynaptic alpha 2-adrenoceptors to xylazine. These results show that the adaptative changes of alpha-adrenoceptors in the rat anococcygeus muscle following long-term administration may depend on the efficiency to inhibit the neuronal uptake and the ability to antagonize alpha 1-adrenoceptors.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.